Oxytocin augmentation in grandmultiparous parturients: to give or not to give? |
| |
Authors: | Yaakov Bentov Eyal Sheiner |
| |
Institution: | (1) Department of Obstetrics and Gynecology, Faculty of Health Services, Soroka University Medical Center, Ben-Gurion University of the Negev, P.O. Box 151, 84101 Beer-Sheva, Israel |
| |
Abstract: | Objective The present editorial was aimed to determine policies toward the use of oxytocin for labor augmentation among grandmultiparous
(above 5 deliveries) parturients (GMPs).
Study design A questionnaire regarding attitudes toward oxytocin augmentation during labor among GMPs was distributed to all chairpersons
of Ob/Gyn departments throughout the country; 20/23 chairpersons responded to the national survey.
Results In all, 85% (17/20) of the chairpersons allowed the use of oxytocin for augmentation of labor in GMPs. Those answering positively
to this question did not choose to limit the use of oxytocin for any level of parity. Moreover, 58% (11/19) of them did not
obligate the concurrent use of intrauterine pressure catheter while using oxytocin augmentation in these patients. Only 22%
(4/18) of the medical centers surveyed limited the maximal dose of Oxytocin among GMPs. The limited dose of oxytocin ranged
from 8 to 16 μ/min. Alternatives for oxytocin augmentation in GMPs were breast stimulation (30%), and surgical induction (15%).
Nevertheless, 50% of the chairpersons found no other suitable alternative for labor augmentation among GMPs.
Conclusion Oxytocin seems like an accepted method for labor augmentation among grandmultiparous women. Moreover, the vast majority of
chairpersons did not mandate additional safety measures such as internal uterine catheter or limited dose regimens in these
patients. |
| |
Keywords: | Grand multiparity Oxytocin Labor augmentation Uterine rupture |
本文献已被 SpringerLink 等数据库收录! |
|